Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk Factors Associated to Difficult-to-control Asthma
NCT01089322Phase 4Completed
- Start
- Dec 2005
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of EPI-EE, formoterol and prednisone in asthma. Primary endpoint: Asthma Control Questionnaire at 12 weeks. Started Dec 2005; status: completed.
02
Drugs
EPI-EEformoterolprednisone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01089322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01089322.